申请人:Selcia Limited
公开号:US20170190734A1
公开(公告)日:2017-07-06
Provided are compounds of Formula I:
and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.